why Arcutis Biotherapeutics Inc [ARQT] is a Good Choice for Investors After New Price Target of $18.57
Arcutis Biotherapeutics Inc [NASDAQ: ARQT] closed the trading session at $10.18. The stocks have a year to date performance of 215.02 percent and weekly performance of 11.08 percent. The stock has been moved at -5.35 percent over the last six months. The stock has performed